D-Mannose acts as a competitive anti-adhesin. UPEC’s type 1 fimbriae end in FimH adhesins that bind strongly to mannose residues on urothelial plakins. Pharmacological concentrations of soluble D-Mannose in urine saturate FimH binding sites, blocking bacterial attachment to the bladder lining and allowing clearance by urine flow. Clinical data show that 2 g daily reduces UTI recurrence rates comparably to low-dose prophylactic antibiotics, without promoting resistance.

Lorbiotics UTI Care
Break the cycle of recurrent UTIs — from the inside. Rebuilds the protective vaginal Lactobacillus barrier that prevents harmful bacteria from causing trouble.
☆☆☆☆☆No reviews yet- Capsules
- Allergen Free
- In Vitro Test
- Clinical Test
- 24 Month Stability
D-Mannose 2g daily reduces UTI recurrence comparably to low-dose prophylactic antibiotics — without promoting antibiotic resistance; combined with L. crispatus vaginal microbiome restoration for comprehensive urogenital protection.
Why UTI Care works.
UTICare is a precision urological synbiotic formulated for the prevention and co-treatment of recurrent urinary tract infections (UTIs), especially bacterial cystitis driven by uropathogenic E. coli (UPEC), which causes over 85% of community-acquired UTIs in women.
It combines four targeted probiotic strains — including the key vaginal-dominant Lactobacillus crispatus — with Cranberry extract, D-Mannose, and Phytosterols to create a multi-layered defence against E. coli adhesion and colonisation in the urogenital tract.
Recurrent UTIs (≥2 episodes in 6 months or ≥3 in 12 months) affect 25–50% of women after an initial infection. UPEC survives by forming protected intracellular bacterial communities (IBCs) inside bladder cells, leading to repeated flares despite antibiotics.
UTIcare tackles this on two fronts:
Luminal defence: D-Mannose and cranberry proanthocyanidins (PACs) prevent E. coli from sticking to the bladder wall.
Vaginal microbiome restoration: Lactobacillus strains (especially L. crispatus) acidify the vagina (pH <4.0), produce hydrogen peroxide, and inhibit E. coli and Gardnerella, reducing the risk of ascending infection.
L. crispatus dominates the healthiest vaginal microbiome (CST I), which is linked to the lowest UTI recurrence rates. Unlike L. iners (associated with dysbiosis), it delivers robust D-lactic acid and H₂O₂ production for superior pathogen protection.
- 01Recurrent UTI preventionD-Mannose competitive FimH saturation blocking UPEC uroepithelial adhesion
- 02P-fimbriae inhibitioncranberry PAC-A prevents UPEC upper urinary tract colonisation and pyelonephritis
- 03Vaginal microbiome restorationL. crispatus re-establishes protective CST-I vaginal microbiome state
- 04Vaginal barrier defencelactic acid, H2O2, and bacteriocin production inhibiting E. coli ascent
- 05Intestinal membrane integrityprobiotic-mediated gut barrier reinforcement reducing enteric E. coli reservoir
- 06Antibiotic-free UTI prophylaxisD-Mannose + cranberry efficacy without resistance selection pressure
“UTICare is a precision urological synbiotic formulated for the prevention and co-treatment of recurrent urinary tract infections (UTIs), especially bacterial cystitis driven by uropathogenic E.”
Lorbiotics UTI Care · Gynaecology
How it works, step by step.
The documented biological pathway — exactly how each component acts inside the body.
Cranberry provides complementary protection via type-A proanthocyanidins (PAC-A1 & PAC-A2), which inhibit UPEC P-fimbriae responsible for upper urinary tract colonization. This helps prevent both cystitis and pyelonephritis.
Lactobacillus probiotic blend restores vaginal colonization resistance by lowering pH through lactic acid production, generating hydrogen peroxide (directly toxic to E. coli), and releasing bacteriocins that competitively exclude pathogens like Gardnerella, thereby strengthening the vaginal barrier against ascending UTIs.
Every ingredient earns its place.
The exact composition of Lorbiotics UTI Care — each organism and active listed at its formulated dose.
| Organism / active | Documented role | Dose |
|---|---|---|
| Lactobacillus crispatus | — | 3 B CFU |
| Lactobacillus plantarum | — | 5 B CFU |
| Lactobacillus paracasei | — | 3 B CFU |
| Streptococcus thermophilus | — | 3 B CFU |
| Cranberry extract (standardised for PAC-A)- as standardized | — | — |
| D-Mannose | — | 2 g |
| Phytosterols | — | as standardized |
How to take it.
Dosage
For active UTI (co-treatment): 2 sachets/capsules daily with antibiotics and for 2 weeks post-treatment. For recurrence prevention: 1 sachet/capsule daily as long-term maintenance. Or as advised by gynaecologist / urologist / physician.
In the pack
Capsule / Sachet · 60 per Pack
With D-Mannose 2 g, Cranberry extract (PAC-A) & Phytosterols. Take daily for long-term UTI prevention.
Certifications
- WHO-GMP
- ISO 13485
- Allergen Free
- Clinical Test
- 24 Month Stability
What people say after they've actually taken it.
No reviews yet
Reviews come from verified buyers only. Once customers who've purchased UTI Care share their experience, you'll see it here.
Peer-reviewed references.
Every claim on this page traces back to published literature. The full citation list for Lorbiotics UTI Care.
- 01Kranjcec B, et al. World J Urol. 2014 32(1):79-84.
- 02Stapleton AE, et al. J Infect Dis. 2011 203(10):1457-64.
- 03Probiotical S.p.A. LPB-GY-UTICARE · L. crispatus + L. plantarum + L. paracasei + S. thermophilus 7B + D-Mannose 2g + Cranberry · 60 Caps


